Hot Supermarket Stocks To Own Right Now

Rite Aid (RAD), the 3rd largest drugstore chain in the U.S., has grown through several major acquisitions over the years. In 2007, the firm purchased the Brooks and Eckerd chains, making it the largest drugstore chain on the East Coast.�

Unfortunately, the company took on the debt and integration issues from this major acquisition just as the country was headed into recession, and it has struggled to regain its footing ever since.

Under the leadership of CEO John Standley, Rite Aid has done the basic blocking and tackling needed to return to profitability. Standley, who had been an executive at Rite Aid in the early 2000��, returned to the company in 2008 after a stint leading the turnaround of Pathmark supermarkets. �

Top Gas Utility Stocks To Invest In 2015: Greif Inc (GEF)

Greif, Inc., incorporated on January 25, 1926, is a producer of industrial packaging products and services with manufacturing facilities located in over 50 countries. The Company offers a line of industrial packaging products, such as steel, fiber and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and reconditioned containers, and services such as container lifecycle management, blending, filling and other packaging services, logistics and warehousing. It also produces containerboard and corrugated products for niche markets in North America. It sells timber to third parties from its timberland in the south-eastern United States. It has four segments: Rigid Industrial Packaging & Services, Flexible Products & Services, Paper Packaging and Land Management.

Rigid Industrial Packaging and Services

In the Rigid Industrial Packaging and Services, the Company is a provider of rigid industrial packaging products, including steel, fiber and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and reconditioned containers, and services, such as container lifecycle management, blending, filling and other packaging services, logistics and warehousing. It sells industrial packaging products to customers in industries, such as chemicals, paints and pigments, food and beverage, petroleum, industrial coatings, agricultural, pharmaceutical and mineral, among others.

Flexible Products and Services segment

In the Flexible Products and Services segment, the Company is a producer of flexible intermediate bulk containers and a North American provider of industrial and consumer multiwall bag products. Its flexible intermediate bulk containers consist of a polypropylene-based woven fabric that is partly produced at its production sites, as well as sourced from strategic regional sup! pliers. Its industrial and consumer multiwall bag products are used to ship a range of industrial and consumer products, such as seed, fertilizers, chemicals, concrete, flour, sugar, feed, pet foods, popcorn, charcoal and salt, primarily for the agricultural, chemical, building products and food industries.

Paper Packaging segment

In the Paper Packaging segment, the Company sells containerboard, corrugated sheets and other corrugated products to customers in North America in industries such as packaging, automotive, food and building products. Its corrugated container products are used to ship such products as home appliances, small machinery, grocery products, building products, automotive components, books and furniture, as well as numerous other applications. Operations related to industrial and consumer multiwall bag products have been reclassified to Flexible Products and Services segment.

Land Management segment

In the Land Management segment, the Company is focused on the active harvesting and regeneration of the United States timber properties to achieve long-term yields. It also sells, from time to time, timberland and special use land, which consists of surplus land, HBU land and development land. As of October 31, 2013, it owned approximately 252,475 acres of timber property in the southeastern United States and approximately 10,300 acres of timber property in Canada.

Advisors' Opinion:

• [By Geoff Gannon]

  For those of you wondering if Greif Brothers Cooperage has any relation to Greif (GEF) ��yes. It has every relation. It�� the same exact company. And it�� still in pretty much the same business. They used to just make barrels. Now they make all kinds of different drums, containers, etc. That�� not a very big change for a company to make over 60 years or so.

Hot Supermarket Stocks To Own Right Now: Lynas Corp Ltd (LYSDY)

Lynas Corporation Limited is engaged in integrated extraction and processing of rare earth minerals, primarily in Australia and Malaysia; and development of Rare Earth deposits. The Company is engaged in commercial production and shipments of Rare Earths products. The Company has Temporary Operating Licence (TOL) for its Lynas Advanced Materials Plant (LAMP). The Company�� subsidiary includes Lynas Malaysia Sdn Bdh, Lynas Services Pty Ltd, Mount Weld Holdings Pty Ltd, Mount Weld Mining Pty Ltd, Lynas Africa Holdings Pty Ltd and Lynas Africa Ltd. Lynas Malaysia Sdn Bdh operates and develops advanced material processing plant. Mount Weld Mining Pty Ltd is engaged in development of mining areas of interest and operation of concentration plant. Lynas Africa Ltd is engaged in mineral exploration. Advisors' Opinion:

• [By Rich Duprey]

  Molycorp also needs to contend with the fact that there's a limited market for the metals it will mine at the same time�Lynas (NASDAQOTH: LYSDY  ) is�already out there producing them in Malaysia, let alone what China itself is bringing to the market. To think it can substantially crack the market at a profitable price in sufficient quantities, even if it does become a low (or the lowest) cost producer, is wishful thinking of the highest order.

Hot Supermarket Stocks To Own Right Now: Toshiba Corp (TOSBF)

TOSHIBA CORPORATION is a Japan-based manufacturer that operates in five business segments. The Digital Product segment manufactures and sells cellular phones, hard disc devices, optical disc devices, televisions among others. The Electronic Device segment provides general logic integrated circuits (ICs), optical semiconductors, power devices, large-scale integrated (LSI) circuits, among others. The Social Infrastructure segment manufactures and sells various generators, power distribution systems, water and sewer systems, transportation systems and station automation systems, among others. The Home Appliance segment provides refrigerators, drying machines, washing machines, cooking utensils, cleaners and lighting equipment, among others. The Others segment is involved in the provision of logistics services. In January 2014, Toshiba Corp purchased substantially all assets of OCZ Technology Group, and launched new subsidiary, OCZ Storage Solutions. Advisors' Opinion:

• [By Bruce Kennedy]

  On Monday, U.S. Attorney General Eric Holder announced indictments against five officers in China's People's Liberation Army (PLA) for ��erious cybersecurity breaches��against six American firms: Westinghouse Electric, a division of Toshiba (OTC: TOSBF) , Alcoa (NYSE: AA),�Allegheny Technologies (NYSE: ATI), U.S. Steel (NYSE: X), the United Steelworkers Union and SolarWorld (OTC: SRWRY).

• [By Dan Carroll and Max Macaluso, Ph.D.]

  Panasonic's (NASDAQOTH: PCRFY  ) not the first company you may think of in the health-care field, but this Japanese electronics maker's a player in blood glucose monitors and other fields. With Panasonic's sales under fire across the board, however, this company's looking to sell off its health-care business to refocus on its core segments. Toshiba (NASDAQOTH: TOSBF  ) reportedly has expressed interest in a buy, and private equity-firms are also in the hunt to get on board with Asia's health-care rise.

Hot Supermarket Stocks To Own Right Now: Alnylam Pharmaceuticals Inc.(ALNY)

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Its core product programs under clinical or pre-clinical development include ALN-TTR, a Phase I clinical trial program for the treatment of transthyretin-mediated amyloidosis; ALN-APC, a Phase I clinical trial program for the treatment of hemophilia; ALN-PCS for the treatment of severe hypercholesterolemia; ALN-HPN, a pre-clinical development for the treatment of refractory anemia; and ALN-TMP, a pre-clinical development for the treatment of hemoglobinopathies, including beta-thalassemia and sickle cell anemia. The company?s partner-based programs comprise ALN-RSV01, a Phase II clinical trial program for the treatment of respiratory syncytial virus infection; ALN-VSP, a Phase I clinical trial completed program for the treatment of liver cancers; and ALN-HTT, a pre-clinical development for the treatment of Huntington?s disease. It has strategic alliances with Novartis Pharma AG; F. Hoffmann-La Roche Ltd; Takeda Pharmaceutical Company Limited; Isis Pharmaceuticals, Inc.; Medtronic Inc.; Kyowa Hakko Kirin Co., Ltd.; and Cubist Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Equities Trading UP
  Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) got a boost, shooting up 53.25 percent to $101.47 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

• [By Keith Speights]

  Early validation
  Alnylam Pharmaceuticals (NASDAQ: ALNY  ) was another big winner this week, with shares jumping 32%. Good news from an early-stage study powered the stock's climb.

• [By Sean Williams]

  RNAi therapeutics expert Alnylam Phrmaceuticals (NASDAQ: ALNY  ) also delivered big gains this week to the tune of 22% after reporting very encouraging mid-stage data for ALN-TTR02, its treatment targeting TTR-mediated amyloidosis. Its experimental drug ALN-TTR02 delivered a 93% reduction in TTR rates in patients, which is perfectly consistent with its early stage results that demonstrated a reduction in TTR rates of 94%. Peak sales estimates, should the drug be approved, range from $800 million to up to $2 billion, but I'd caution investors keep a level head on their shoulders in the meantime.

• [By Jake L'Ecuyer]

  Equities Trading UP
  Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) got a boost, shooting up early in the day, but settling on a gain of 40.40 percent to $92.96 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

Hot Supermarket Stocks To Own Right Now: Vanguard Short-Term Bond ETF (BSV)

Vanguard Short-Term Bond ETF (the Fund) seeks to track the performance of a market-weighted bond index with a short-term, dollar-weighted average maturity. The Fund employs a passive management or indexing strategy designed to track the performance of the Barclays Capital U.S. 1-5 Year Government/Credit Bond Index (the Index). The Index includes all medium and larger issues of the United States Government, investment-grade corporate, and investment-grade international dollar-denominated bonds that have maturities of between 1 and 5 years and are publicly issued. The Fund invests by sampling the Index, meaning that it holds a range of securities that, in the aggregate, approximates the full Index in terms of key risk factors and other characteristics. All of the Fund�� investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the Index. The Fund�� investment advisor is The Vanguard Group, Inc. Advisors' Opinion:

• [By GURUFOCUS]

  In addition to individual stocks several funds pay a monthly dividend. Below is a sampling of these:
  Monthly Bond Funds- iShares Barclays 1-3 Year Credit Bond (CSJ) | Yield: 1.29%
  - Vanguard Short-Term Bond ETF (BSV) | Yield: 1.25%
  - Vanguard Intermediate-Term Bond ETF (BIV) | Yield: 2.96%
  - Vanguard Long-Term Bond ETF (BLV) | Yield: 4.42%

Hot Supermarket Stocks To Own Right Now: Incyte Corporation(INCY)

Incyte Corporation focuses on the discovery and development of proprietary small molecule drugs for hematologic and oncology indications, and inflammatory and autoimmune diseases. Its product pipe line includes INCB18424, which is in Phase III clinical trial for myelofibrosis; Phase III trial for polycythemia vera; Phase III trial for essential thrombocythemia; Phase I/II trial to treat solid tumors/other hematologic malignancies; and Phase IIb trail for the treatment of psoriasis. The company?s portfolio also includes INCB28050, a Phase IIb clinical trial product for rheumatoid arthritis; INCB28060, a Phase I/II product for solid tumors; INCB7839, a Phase II product for breast cancer; and INCB24360, a Phase I/II product for solid tumors. It has a collaborative research and license agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; and Pfizer Inc. The company was founded in 1991 and is headquartered in Wilmington, Delaware.

Advisors' Opinion:

• [By Jay Silverman]

  Steve Halpern: One of your long-standing recommendations is Incyte (INCY), which recently reported some positive news and saw a huge jump in the price-up close to 30% in one day. What happened there and what's your outlook for the stock?

• [By Maxx Chatsko]

  The company was also hoping to crack into the rheumatoid arthritis market with tabalumab, which kept the streak of ineffective treatments going for shareholders. Despite losing out on this massive market initially, Eli Lilly does have a promising JAK inhibitor (baricitinib) being developed with Incyte (NASDAQ: INCY  ) for the disease and an additional trial for psoriasis. If successful, safe, and effective, the oral treatment could be more convenient for patients currently taking injectable biologics. �

• [By Paul Ausick]

  Big earnings winners: Incyte Corp. (NASDAQ: INCY) up 34.4% to $36.02 on a successful drug trial, Target Corp. (NYSE: TGT) down 3.5% to $65.54 on weak earnings and lowered outlook, and Lowe�� Companies Inc. (NYSE: LOW ) up 4.4% at $46.01 on strong earnings and an improved outlook.

Hot Supermarket Stocks To Own Right Now: Intuit Inc.(INTU)

Intuit Inc. provides business and financial management solutions for small and medium-sized businesses, consumers, accounting professionals, and financial institutions primarily in the United States, Canada, India, Singapore, and the United Kingdom. The company offers QuickBooks financial and business management software and services, technical support, financial supplies, and Web site design and hosting services for small and medium-sized businesses; and payroll products and services, as well as merchant services comprising credit and debit card processing, electronic check conversion, and automated clearing house services for small businesses. It also provides TurboTax income tax preparation products and services for consumers and small business owners; Lacerte and ProSeries professional tax products and services; and QuickBooks Premier Accountant Edition and the QuickBooks ProAdvisor Program for accounting professionals. In addition, the company offers outsourced online financial management solutions for banks and credit unions; Quicken personal finance products and services; Mint.com online personal finance services; and Intuit Health online patient-to-provider communication solutions. It sells its products and services through various sales and distribution channels, including Websites, promotions, retail channels, and call centers, as well as through alliance partners, principally consisting of banks, credit unions, and securities and investment firms. The company was founded in 1983 and is headquartered in Mountain View, California.

Advisors' Opinion:

• [By Sue Chang and Saumya Vaishampayan]

  INTU: Intuit Inc. (INTU) �shares recovered from earlier losses to rise 0.8%. The tax software company on Tuesday said its fiscal third-quarter profit rose 20% to $984 million, or $3.39 a share. Excluding items, the company said it earned $3.53 a share. The company had previously forecast per-share earnings of $3.46 to $3.51.

• [By Michael Lewis]

  Sea change
  As with many industries, tax prep is witnessing a period of technological disruption in the form of Web-based software. Intuit (NASDAQ: INTU  ) is the leader in the space with its Turbo Tax product. Lesser-known Blucora (NASDAQ: BCOR  ) has its hand in the game as well with TaxACT. The latter is a small but healthy business. TaxACT maintains strong margins and grows at roughly 8% to 10% annually. Currently, the company maintains around 12% of online tax-prep market share.

• [By Amanda Alix]

  Recently, al-Qassam reemerged after a break, threatening more mayhem. American Banker�quoted an analyst from Intuit (NASDAQ: INTU  ) , a business and financial software provider, as noting that DDoS attacks "have less of an impact" on banks' business than those designed to hide more nefarious cyber activities. Another analyst from NSS Labs, an information and security research and advisory firm, stated that DDoS assaults in and of themselves don't really cost banks much, though they are inconvenient for customers.